This activity is expired and is no longer available for CME credit.


Central and Branch Retinal Vein Occlusion Clinical Trials: A Comprehensive Review

Author(s)/Faculty: Michael S. Ip, MD
Release Date: 3/25/2016Expiration Date: 3/25/2017
Credit Type: CMENumber of Credits: 0
Content Type: ArticleProvider:

Prior to 2009, there were no proven effective therapies for vision loss from macular edema due to a central retinal vein occlusion (CRVO). The only option for macular edema that developed from a branch retinal vein occlusion (BRVO) was focal laser macular photocoagulation. Starting in 2009, a series of clinical trial reports was published, many of which provided Level 1 evidence, demonstrating the efficacy of new therapies for both CRVO and BRVO. Data from many of these trials supported FDA approval of new treatments.